On June 9, MDS Nordion of Ottawa began the manufacture of CardioGen-82 (rubidium-82 generator) for Bracco Diagnostics of Princeton, NJ.
The production is taking place at MDS Nordion's recently completed manufacturing suite within its production facility in Kanata.
CardioGen-82 is a cardiac perfusion imaging agent used in PET imaging and approved by the U.S. Food and Drug Administration (FDA).
Related Reading
MDS advocates Maple reactor activation, June 1, 2009
MDS Nordion opens new FDG facility in Belgium, May 28, 2009
MDS Nordion to partner on isotope alternative study, April 28, 2009
Mallinckrodt sues Bracco, April 9, 2009
Court orders GE to pay Bracco, correct Visipaque ads, March 30, 2009
Bracco revisits plans for U.S. launch of SonoVue, March 8, 2009
Copyright © 2009 AuntMinnie.com
